QCM
REGN icon

Quest Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quest Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-361
Closed -$202K – 306
2021
Q2 		$202K Buy
+361
New +$183K 0.04% 279

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Quest Capital Management's REGN Position: Q3 2021 in Review

Quest Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 361 shares — an estimated $202K sold.

Quest Capital Management first reported a position in REGN in Q2 2021 and held it in 1 quarter. The position peaked at $202K in Q2 2021. 1,017 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Quest Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Quest Capital Management sold 361 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $202K.
  • Quest Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Quest Capital Management's Regeneron Pharmaceuticals position peaked at $202K in Q2 2021.
  • 1,017 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Quest Capital Management's 13F filing for Q3 2021, filed 1 Nov 2021.